QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
NASDAQ:ARDS

Aridis Pharmaceuticals - ARDS Earnings Date, Estimates & Call Transcripts

$0.40
-0.01 (-2.44%)
(As of 03/24/2023 05:31 PM ET)
Add
Compare
Today's Range
$0.39
▼
$0.41
50-Day Range
$0.36
▼
$1.30
52-Week Range
$0.35
▼
$2.77
Volume
268,809 shs
Average Volume
1.73 million shs
Market Capitalization
$8.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ARDS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARDS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aridis Pharmaceuticals Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.69 EPS
Next Year EPS Consensus Estimate: $-0.46 EPS

ARDS Earnings Date and Information

Aridis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off prior year's report dates.

Aridis Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/30/2023
(Estimated)		        
11/21/2022Q3 2022($0.01)($0.42)($0.41)($0.37)$11.20 million$0.40 million
8/16/2022Q2 2022($0.06)($0.45)($0.39)($0.45)$10.47 million$0.29 million
5/16/2022Q1 2022($0.51)($0.44)+$0.07($0.44)$2.00 million$1.19 million
3/31/2022Q4 2021($0.58)($0.92)($0.34)($0.92)$5.70 million$0.57 million
11/10/20219/30/2021($0.51)($1.94)($1.43)($1.94)$0.52 million
8/11/20216/30/2021($0.63)($0.55)+$0.08($0.61)$0.40 million$0.03 million    
5/11/20213/31/2021($0.60)($0.77)($0.17)($0.77)
3/29/202112/31/2020($0.59)($0.59)($0.59)
11/19/20209/30/2020($0.55)($0.65)($0.10)($0.65)
8/11/2020Q2 2020($0.7440)($0.47)+$0.2740($0.47)$0.75 million$1.00 million
5/12/2020Q1 2020($0.67)($0.73)($0.06)($0.73)$0.75 million
4/8/2020Q4($0.8080)($0.63)+$0.1780($0.63)
11/13/2019Q3($0.33)($0.87)($0.54)($0.87)$1.50 million
8/12/2019Q2 2019($0.84)($1.03)($0.19)($1.03)
5/14/2019Q1($0.8670)($0.99)($0.1230)($0.99)$1.02 million
3/28/2019Q4($1.5530)($0.67)+$0.8830($0.67)$0.30 million$1.39 million
11/13/2018Q3 2018($1.05)($1.97)($0.92)($1.27)$0.33 million$1.02 million












Aridis Pharmaceuticals Earnings - Frequently Asked Questions

When is Aridis Pharmaceuticals's earnings date?

Aridis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 30th, 2023 based off last year's report dates. Learn more on ARDS's earnings history.

How much revenue does Aridis Pharmaceuticals generate each year?

Aridis Pharmaceuticals (NASDAQ:ARDS) has a recorded annual revenue of $1.53 million.

How much profit does Aridis Pharmaceuticals generate each year?

Aridis Pharmaceuticals (NASDAQ:ARDS) has a recorded net income of -$42.19 million. ARDS has generated -$2.28 earnings per share over the last four quarters.

What is Aridis Pharmaceuticals's EPS forecast for next year?

Aridis Pharmaceuticals's earnings are expected to grow from ($1.69) per share to ($0.46) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:ARDS) was last updated on 3/24/2023 by MarketBeat.com Staff